IBM uses AI to evaluate risk of developing genetic diseases
August 20, 2020
In a study published in the journal Nature Communications, scientists at IBM, the Broad Institute of MIT and Harvard, and health tech company Color find evidence that the presence of genetic mutations isn’t a reliable precursor to genetic diseases. They claim diseases can be so greatly influenced by other factors that the risk in carriers is sometimes as low as in that of noncarriers.
The…